Education
About Us
Working with TipRanks
Follow Us
COSMO Pharmaceuticals N.V. (CH:COPN)
:COPN
RESEARCH TOOLSreports
Total Valuation
COSMO Pharmaceuticals N.V. has a market cap or net worth of CHF958.07M. The enterprise value is CHF1.00B.
Market CapCHF958.07M
Enterprise ValueCHF1.00B
Share Statistics
COSMO Pharmaceuticals N.V. has 17,543,522 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding17,543,522
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
COSMO Pharmaceuticals N.V.’s return on equity (ROE) is 0.27 and return on invested capital (ROIC) is 21.57%.
Return on Equity (ROE)0.27
Return on Assets (ROA)0.21
Return on Invested Capital (ROIC)21.57%
Return on Capital Employed (ROCE)0.25
Revenue Per Employee831.12K
Profits Per Employee477.78K
Employee Count321
Asset Turnover0.41
Inventory Turnover1.47
Valuation Ratios
The current PE Ratio of COSMO Pharmaceuticals N.V. is 8.32. COSMO Pharmaceuticals N.V.’s PEG ratio is -3.17.
PE Ratio8.32
PS Ratio0.00
PB Ratio2.22
Price to Fair Value2.22
Price to FCF39.17
Price to Operating Cash Flow30.55
PEG Ratio-3.17
Income Statement
In the last 12 months, COSMO Pharmaceuticals N.V. had revenue of 266.79M and earned 133.24M in profits. Earnings per share was 8.15.
Revenue266.79M
Gross Profit246.92M
Operating Income148.88M
Pretax Income153.37M
Net Income133.24M
EBITDA165.71M
Earnings Per Share (EPS)8.15
Cash Flow
In the last 12 months, operating cash flow was 162.41M and capital expenditures -5.65M, giving a free cash flow of 156.76M billion.
Operating Cash Flow162.41M
Free Cash Flow156.76M
Free Cash Flow per Share8.94
Dividends & Yields
COSMO Pharmaceuticals N.V. pays an annual dividend of CHF1.65, resulting in a dividend yield of 2.91%
Dividend Per ShareCHF1.65
Dividend Yield2.91%
Payout Ratio86.04%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.01
52-Week Price Change-14.41%
50-Day Moving Average52.12
200-Day Moving Average59.74
Relative Strength Index (RSI)55.62
Average Volume (3m)21.31K
Important Dates
COSMO Pharmaceuticals N.V. upcoming earnings date is Jul 23, 2025, Before Open (Confirmed).
Last Earnings DateMar 6, 2025
Next Earnings DateJul 23, 2025
Ex-Dividend DateJun 04, 2025
Financial Position
COSMO Pharmaceuticals N.V. as a current ratio of 4.19, with Debt / Equity ratio of 37.99%
Current Ratio4.19
Quick Ratio3.91
Debt to Market Cap<0.01
Net Debt to EBITDA-0.25
Interest Coverage Ratio2.81K
Taxes
In the past 12 months, COSMO Pharmaceuticals N.V. has paid 20.18M in taxes.
Income Tax20.18M
Effective Tax Rate0.13
Enterprise Valuation
COSMO Pharmaceuticals N.V. EV to EBITDA ratio is 6.44, with an EV/FCF ratio of 6.80.
EV to Sales4.00
EV to EBITDA6.44
EV to Free Cash Flow6.80
EV to Operating Cash Flow6.57
Balance Sheet
COSMO Pharmaceuticals N.V. has CHF142.96M in cash and marketable securities with €2.20M in debt, giving a net cash position of -CHF140.76M billion.
Cash & Marketable SecuritiesCHF142.96M
Total Debt€2.20M
Net Cash-CHF140.76M
Net Cash Per Share-CHF8.02
Tangible Book Value Per ShareCHF9.12
Margins
Gross margin is 81.62%, with operating margin of 55.81%, and net profit margin of 49.94%.
Gross Margin81.62%
Operating Margin55.81%
Pretax Margin57.49%
Net Profit Margin49.94%
EBITDA Margin62.11%
EBIT Margin57.51%
Analyst Forecast
The average price target for COSMO Pharmaceuticals N.V. is CHF100.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price TargetCHF100.00
Price Target Upside75.75% Upside
Analyst ConsensusModerate Buy
Analyst Count1
Revenue Growth Forecast182.25%
EPS Growth Forecast―